Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06844045 · ClinicalTrials.gov registry record · NA
Point of Care STI Testing
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 6,460
- Enrollment target
NCT06844045: Recruiting NA study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06844045 is a NA study that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 6,460 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (360% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06844045, a NA study, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 6,460 participants
- Enrollment target
Study Summary
The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.
Primary Outcome
Rates of HIV test completion on the day of gonorrhea/chlamydia testing will be compared between those who receive point-of-care vs. lab-based STI testing.
Interventions
- BEHAVIORAL Gonorrhea/chlamydia Point-of-Care Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,460 participants |
| Start Date | 2026-02-24 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06844045 shows while recruiting
NCT06844045 is an interventional study that assigns participants to a tested intervention. Its 6,460 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (360% higher).
The record links to 0 conditions, and to 1 intervention - of which Gonorrhea/chlamydia Point-of-Care Testing is the first listed.
NCT06844045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06844045 about?
NCT06844045 is a clinical study titled "Point of Care STI Testing". The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasi...
What is the current status of trial NCT06844045?
This trial is currently recruiting. It is a NA study. The enrollment target is 6,460 participants. The study started on 2026-02-24. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT06844045?
The interventions under investigation include: Gonorrhea/chlamydia Point-of-Care Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT06844045?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06844045's enrollment target sits among peer trials
6,460 21st of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00505245 · 6,500 participants
New Assessment System in Measuring Symptom Distress in Cancer Patients
- NCT06821009 · 6,500 participants · NA
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
- NCT05369429 · 6,516 participants · NA
My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI